Zhejiang Tianyu Pharmaceutical Co., Ltd. is a leading company in the pharmaceutical industry, specializing in the research, development, and manufacture of active pharmaceutical ingredients (APIs). With a focus on producing high-quality and cost-effective pharmaceutical raw materials, the company plays a critical role in the global supply chain for drugs and medicines. Zhejiang Tianyu's extensive product portfolio serves a wide range of therapeutic areas including anti-diabetic, cardiovascular, and central nervous system diseases.
Founded in China, the company has established a significant presence in the international pharmaceutical market, adhering to stringent quality standards and regulations like Good Manufacturing Practice (GMP). As a result, it has garnered approvals from major health authorities, including the FDA and EMEA. Zhejiang Tianyu Pharmaceutical Co., Ltd. supports diverse sectors within the healthcare industry, from generic drug manufacturers to multinational pharmaceutical enterprises. By facilitating the supply of essential APIs, Zhejiang Tianyu is integral to advancing healthcare outcomes and the continuous development of new medicinal therapies across various markets worldwide.
Markedsdata leveret af TwelveData og Morningstar
Baseret på 2 analytikere